These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 2401172

  • 1. [Evaluation of RPHA fecal occult blood test in screening for colorectal cancer].
    Yu H.
    Zhonghua Zhong Liu Za Zhi; 1990 Mar; 12(2):108-10. PubMed ID: 2401172
    [Abstract] [Full Text] [Related]

  • 2. [The screening model for early diagnosis of colorectal cancer in general population].
    Zheng S.
    Zhonghua Yi Xue Za Zhi; 1991 Jul; 71(7):381-4, 28. PubMed ID: 1659480
    [Abstract] [Full Text] [Related]

  • 3. [Evaluation of mass screening for colorectal cancer with 'sequential fecal occult blood test' in an asymptomatic population. Multicenter GI Research Group of Beijing Area of PLA].
    Zhonghua Zhong Liu Za Zhi; 1993 May; 15(3):230-3. PubMed ID: 8261874
    [Abstract] [Full Text] [Related]

  • 4. [Mass screening for colorectal cancer by occult blood testing under restricted diet].
    Fujita M, Taguchi T, Nakano Y, Oota J, Kimoto Y, Kumanishi Y, Oomichi M, Usugane M, Ueda N, Tsukahara Y.
    Gan No Rinsho; 1984 Jul; 30(8):925-32. PubMed ID: 6471396
    [Abstract] [Full Text] [Related]

  • 5. [An applied study on the method of multi-factorial quantitative-risk assessment (MFQRA) for mass screening of colorectal cancer].
    Chen K.
    Zhonghua Zhong Liu Za Zhi; 1993 Jan; 15(1):37-40. PubMed ID: 8334938
    [Abstract] [Full Text] [Related]

  • 6. [Occult blood screening for colorectal cancer].
    Kumanishi Y, Fujita M, Taguchi T.
    Gan To Kagaku Ryoho; 1986 Jul; 13(7):2255-62. PubMed ID: 3729485
    [Abstract] [Full Text] [Related]

  • 7. Results of screening for colorectal cancer.
    Crespi M, Casale V, Grassi A, Caperle M, Casale G, Conti E.
    Endoscopy; 1981 Sep; 13(5):203-6. PubMed ID: 7274170
    [Abstract] [Full Text] [Related]

  • 8. Many participants in fecal occult blood test population screening have a higher-than-average risk for colorectal cancer.
    Worthley DL, Smith A, Bampton PA, Cole SR, Young GP.
    Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1079-83. PubMed ID: 16957514
    [Abstract] [Full Text] [Related]

  • 9. Mass screening for colorectal cancer by testing for occult blood under restricted diet and a questionnaire in Osaka.
    Fujita M, Nakano Y, Ohta J, Kumanishi Y, Taguchi T.
    Cancer Detect Prev; 1987 Oct; 10(5-6):353-60. PubMed ID: 3568034
    [Abstract] [Full Text] [Related]

  • 10. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics.
    Allison JE, Sakoda LC, Levin TR, Tucker JP, Tekawa IS, Cuff T, Pauly MP, Shlager L, Palitz AM, Zhao WK, Schwartz JS, Ransohoff DF, Selby JV.
    J Natl Cancer Inst; 2007 Oct 03; 99(19):1462-70. PubMed ID: 17895475
    [Abstract] [Full Text] [Related]

  • 11. [Evaluation of combined test of sequential fecal occult blood and albumin in the screening of colorectal neoplasms].
    Li S, Zhang C, Xu E.
    Zhonghua Zhong Liu Za Zhi; 1995 Sep 03; 17(5):381-3. PubMed ID: 8697982
    [Abstract] [Full Text] [Related]

  • 12. Colorectal cancer screening: new opportunities.
    Levin TR.
    Surg Oncol Clin N Am; 1999 Oct 03; 8(4):673-91, vi-vii. PubMed ID: 10452934
    [Abstract] [Full Text] [Related]

  • 13. Clinicopathologic significance of immunohistochemical fecal occult blood test in subjects receiving bidirectional endoscopy.
    Liu HH, Huang TW, Chen HL, Wang TH, Lin JT.
    Hepatogastroenterology; 2003 Oct 03; 50(53):1390-2. PubMed ID: 14571744
    [Abstract] [Full Text] [Related]

  • 14. [Evaluation of usefulness of faecal occult blood test. Prospective screening study in patients with colorectal neoplasia].
    Banaszkiewicz Z, Jawień A, Jarmocik P, Tojek K, Jankowski M, Switoński M.
    Pol Merkur Lekarski; 2004 Dec 03; 17(102):579-82. PubMed ID: 15771126
    [Abstract] [Full Text] [Related]

  • 15. Nonmedical costs of colorectal cancer screening with the fecal occult blood test and colonoscopy.
    Heitman SJ, Au F, Manns BJ, McGregor SE, Hilsden RJ.
    Clin Gastroenterol Hepatol; 2008 Aug 03; 6(8):912-917.e1. PubMed ID: 18534918
    [Abstract] [Full Text] [Related]

  • 16. A prospective multicenter evaluation of new fecal occult blood tests in patients undergoing colonoscopy.
    Greenberg PD, Bertario L, Gnauck R, Kronborg O, Hardcastle JD, Epstein MS, Sadowski D, Sudduth R, Zuckerman GR, Rockey DC.
    Am J Gastroenterol; 2000 May 03; 95(5):1331-8. PubMed ID: 10811348
    [Abstract] [Full Text] [Related]

  • 17. [Repeat mass screening for fecal occult blood for the diagnosis of colorectal neoplasms in a rural district. Results of an informational campaign].
    Hofbauer F, Mach K, Egermann G.
    Wien Klin Wochenschr; 1991 May 03; 103(10):288-95. PubMed ID: 1858377
    [Abstract] [Full Text] [Related]

  • 18. An adapted program of colorectal cancer screening--7 years experience and cost-benefit analysis.
    Fric P, Zavoral M, Dvoráková H, Zoubek V, Roth Z.
    Hepatogastroenterology; 1994 Oct 03; 41(5):413-6. PubMed ID: 7851847
    [Abstract] [Full Text] [Related]

  • 19. Performance characteristics and evaluation of an automated-developed and quantitative, immunochemical, fecal occult blood screening test.
    Vilkin A, Rozen P, Levi Z, Waked A, Maoz E, Birkenfeld S, Niv Y.
    Am J Gastroenterol; 2005 Nov 03; 100(11):2519-25. PubMed ID: 16279909
    [Abstract] [Full Text] [Related]

  • 20. Occult-blood screening for colorectal carcinoma: the risks.
    Frank JW.
    Am J Prev Med; 1985 Nov 03; 1(4):25-32. PubMed ID: 3870908
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.